Position
Director
Company
HaemaLogiX
SydneyManufacturingBiotechnologyHealth CareTherapeuticsDescription
HaemaLogiX Ltd is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to the HaemaLogiX Board as a Non-Executive Director. This appointment marks the first corporate directorship that Prof Hunt has accepted since completing his period as Minister for Health.
Quick answer
HaemaLogiX Appoints Professor the Hon Greg Hunt as Non-Executive Director (May 20, 2024). HaemaLogiX is based in Sydney, New South Wales, Australia.
- Who is the new Director at HaemaLogiX?
- HaemaLogiX named Hon Greg Hunt Director, announced May 20, 2024.
- What did HaemaLogiX announce on May 20, 2024?
- HaemaLogiX Ltd is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to the HaemaLogiX Board as a Non-Executive Director. This appointment marks the first corporate directorship that Prof Hunt has accepted since completing his period as Minister for Health.
- What does HaemaLogiX do?
- HaemaLogiX focus is the development and commercialisation of novel immuno-oncology and immune-therapies.
- Where is HaemaLogiX based?
- HaemaLogiX is based in Sydney, New South Wales, Australia.
- Which similar companies made leadership changes around the same time?
- Teva Pharmaceutical Industries Ltd (May 15, 2024), YS Biopharma (May 7, 2024), Contineum Therapeutics (June 3, 2024) and AbbVie Inc. (June 20, 2024) also announced leadership changes within 45 days of HaemaLogiX.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Teva Pharmaceutical Industries Ltd. Appoints Matthew Shields as Executive Vice President of Teva Global Operations (May 15, 2024)
- YS Biopharma Appoints Dave Chenn as Interim CEO and Hui Shao as Co-CEO and CBO (May 7, 2024)
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
- AbbVie Appoints Roxanne S. Austin as Lead Independent Director (June 20, 2024)
- Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer (May 20, 2024)
- Octapharma USA Appoints Kelly Hearn as Vice President of Commercial Development & Marketing (May 20, 2024)
Who to call at HaemaLogiX, and when
A new leader at HaemaLogiX brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day HaemaLogiX raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HaemaLogiX, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HaemaLogiX. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HaemaLogiX changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HaemaLogiX changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.